𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer

✍ Scribed by Claudia B.M. Bijen; Enja J. Bantema-Joppe; Renske A. de Jong; Ninke Leffers; Marian J.E. Mourits; Henk F. Eggink; Ate G.J. van der Zee; Harry Hollema; Geertruida H. de Bock; Hans W. Nijman

Publisher
John Wiley and Sons
Year
2010
Tongue
French
Weight
462 KB
Volume
126
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The aim of this study was to investigate classical MHC class I and nonclassical MHC (human leukocyte antigen‐G [HLA‐G]) expression in a large cohort of patients with endometrial cancer, to determine the prognostic value of these cell surface markers and their relation with clinicopathological variables. Tissue microarrays containing epithelial endometrial carcinoma tissue from 554 patients were stained for classical and nonclassical MHC class I using the following monoclonal antibodies: 4H84 (anti‐HLA‐G), β2‐m (anti‐beta‐2‐microglobulin) and HC‐10 (MHC class I antigen heavy chain). Expression data were linked to known clinicopathological characteristics and survival. HLA‐G upregulation and MHC class I downregulation in neoplastic cells was observed in 40% and 48%, respectively. Nonendometrioid tumor type, advanced stage disease (FIGO stage ≥II) and poorly or undifferentiated tumors were associated with MHC class I downregulation. Absence of HLA‐G expression was independently associated with MHC class I downregulation. In univariate analysis, MHC class I downregulation was a predictor of worse disease‐specific survival. Prognostic unfavorable tumor characteristics were correlated with downregulation of MHC class I expression in endometrial cancer cells. Furthermore, downregulated MHC class I has a negative impact on disease‐specific survival, observed in a large cohort of patients with endometrial cancer. As there seems to be a relation between classical and nonclassical MHC class I molecules (HLA‐G), further research is warranted to unravel this regulatory mechanism.

📜 SIMILAR VOLUMES

Regulation of the expression of MHC clas
Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells
✍ Aichun Liu; Masuhiro Takahashi; Ken Toba; Zhiyin Zheng; Shigeo Hashimoto; Kohji 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 437 KB 👁 2 views

In order to develop an effective immunotherapy for hematological malignancies, we investigated the applicability of class II transactivator (CIITA), which had been demonstrated to regulate the expression of MHC class II (MHC-II) by assembling the transcription factors of MHC-II molecules, for immuno

A major role for tapasin as a stabilizer
A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression
✍ Natalio Garbi; Neeraj Tiwari; Frank Momburg; Günter J. Hämmerling 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Tapasin is a member of the MHC class I loading complex where it bridges the TAP peptide transporter to class I molecules. The main role of tapasin is assumed to be the facilitation of peptide loading and optimization of the peptide cargo. Here, we describe another important function for tapasin. In

The level of expression of class-I MHC a
The level of expression of class-I MHC antigens in adenovirus-transformed human cell lines
✍ Roger J. A. Grand; Martin Rowe; Philip J. Byrd; Phillip H. Gallimore 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 994 KB

The level of expression of the class-I major histocompatibil-19 and 54kDa. The El region encompasses those viral genes ity (MHC) antigen was determined in a series of human em-expressed first following lytic infection and is also that area bryo cell lines transformed with either adenovirus I2 (Ad 12